pDONR221_MPC2 Citations (1)
Originally described in: The RESOLUTE consortium: unlocking SLC transporters for drug discovery.Superti-Furga G, Lackner D, Wiedmer T, Ingles-Prieto A, Barbosa B, Girardi E, Goldmann U, Gurtl B, Klavins K, Klimek C, Lindinger S, Lineiro-Retes E, Muller AC, Onstein S, Redinger G, Reil D, Sedlyarov V, Wolf G, Crawford M, Everley R, ... Steppan CM Nat Rev Drug Discov. 2020 Jul;19(7):429-430. doi: 10.1038/d41573-020-00056-6. PubMed Journal
Articles Citing pDONR221_MPC2
| Articles |
|---|
| MPC2 variants disrupt mitochondrial pyruvate metabolism and cause an early-onset mitochondriopathy. Pujol C, Lebigot E, Gaignard P, Galai S, Kraoua I, Bault JP, Dard R, Youssef-Turki IB, Omar S, Boutron A, Wai T, Slama A. Brain. 2023 Mar 1;146(3):858-864. doi: 10.1093/brain/awac444. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.